U.S. regulators have strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
WASHINGTON — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities for months have recommended that Americans starting their COVID-19 vaccinations use the Pfizer or Moderna shots instead.FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.
The decision is the latest restriction to hit J&J’s one-dose vaccine, which has long been overshadowed by the more effective two shots from Pfizer and Moderna.In December, the Centers for Disease Control and Prevention recommended prioritizing the Moderna and Pfizer shots over J&J’s because of its safety issues. Previously U.S. officials had treated all three vaccines similarly because they’d each been shown to offer strong protection.
But follow-up studies have consistently shown lower effectiveness for J&J’s vaccine. And while the blood clots seen with J&J’s shot are rare, officials say they’re still occurring. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA puts strict limits on Johnson & Johnson Covid-19 vaccineThe US Food and Drug Administration announced Thursday that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen Covid-19 vaccine to people 18 and older for whom other vaccines aren't appropriate or accessible and those who opt for J&J because they wouldn't otherwise get vaccinated.
Read more »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Read more »
FDA restricts J&J's COVID-19 vaccine due to blood clot riskWASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.
Read more »
Nearly 15 million deaths associated with COVID-19, says WHOThe World Health Organization estimates that nearly 15 million people were killed either by coronavirus or by its impact on overwhelmed health systems in the past two years, more than double the of…
Read more »
Utah COVID-19 case counts have increased, but virus rates in wastewater are leveling, state reportsThe number of new COVID-19 cases that Utah announced Thursday in its now-weekly report was nearly double the amount of cases reported last week.
Read more »
WHO: Nearly 15 million deaths associated with COVID-19The World Health Organization estimates that nearly 15 million people were killed either by coronavirus or by its impact on overwhelmed health systems in the past two years, more than double the official death toll of 6 million.
Read more »